Received Sep 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | MG5S9 | IM / LA |
Reported Symptoms: 10037087:PRURITUS; 10037844:RASH; 10042674:SWELLING; Narrative: Per provider note on 9/10/25 65 year old MALE with DM on insulin, active smoking, and HL, with today's door visit to follow-up ED visit for rash patients concern re reaction to shingles vaccine ## LE Rash and swelling - reports developing red dots on the distal LE beginning early July followed by swelling of the ankle and feet. - 8/15/2025 ED for bilateral LE rash. vitals normal. No description of rash. Negative ROS. CBC and CMP unremarkable, syphilis nonreactive, HIV negative, HCV negative. Unclear A/P in JLV but ICD diagnosis petechial rash and Rx'd loratadine. - he went to hospital 2 days later, disappointed w lack of tx at other hospital. This note is not avail. He was rx'd prednisone 60mg daily x 7 days. - The rash improved during the steroid course and the swelling completely resolved. - Today he has some residual rash which is flat/nonpalpable and remains nonpainful and nonpruritic - no focal or systemic illness preceding the onset of rash. - shingles vaccine delivered June 24, 2025. apart from that, there were no new medicines. - no travel, new pets, new bath/laundry products. No EtOH. A/P Erythematous macular rash (likely petechial in mid August per ED ICD 10), with edema, of unclear cause. The one potential inciting factor is the Shingrix vaccine/24. Hypersensitivity vasculitis seems likely, given the clear response to steroids. This is relatively long post Shingrix vaccine, but still plausible. Reassuring that there were no systemic